UPC_APP_17607/2025

RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME

Procedural & sub-applicationsWithdrawal ApplicationsMilan CDApplication Rop 265—Settled at: Pre-merits

2025-04-22WithdrawnproceduralApplication Rop 265
The Milan Central Division allowed Pfizer's withdrawal of both the revocation action (ACT_45928/2024) and the counterclaim for revocation (CC_60908/2024) against GlaxoSmithKline Biologicals SA concerning EP 4 183 412 (RSV vaccine patent), with GSK's consent and without a cost decision; 60% of court fees were reimbursed to Pfizer.